Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISDIPLAM vs RITUXAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISDIPLAM vs RITUXAN: Safety Overview

Metric RISDIPLAM RITUXAN
Total FAERS Reports 3,619 487
Deaths Reported 336 71
Death Rate 9.3% 14.6%
Hospitalizations 719 160
Average Patient Age 21.8 yrs 60.1 yrs
% Female Patients 55.2% N/A
FDA Approval Date Aug 7, 2020 N/A
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A